In women, the risk of developing osteoporosis increases at the perimenopausal ages, which is accompanied by an increase in FSH levels, supporting the hypothesis that osteoporosis is closely linked to hormonal changes during the menopausal transition (Cannarella et al., 2019; Bergamini et al., 2024). This evidence concerns the gene BRD2 and osteoporosis.